Unraveling the Catalytic Pathway of Metalloenzyme Farnesyltransferase through QM/MM Computation

被引:28
作者
Ho, Ming-Hsun [1 ,2 ]
De Vivo, Marco [1 ,2 ,3 ]
Dal Peraro, Matteo [4 ]
Klein, Michael L. [1 ,2 ]
机构
[1] Univ Penn, Ctr Mol Modeling, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA
[3] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy
[4] Ecole Polytech Fed Lausanne, Lab Biomol Modeling, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland
基金
美国国家卫生研究院;
关键词
FARNESYL-PROTEIN TRANSFERASE; MOLECULAR-DYNAMICS; PHASE-I; PHOSPHATASE-ACTIVITY; CRYSTAL-STRUCTURE; TERNARY COMPLEX; RAT-BRAIN; INHIBITORS; MECHANISM; PEPTIDE;
D O I
10.1021/ct8004722
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The protein farnesyltransferase (FTase) is a Zn2+-metalloenzyme that catalyzes the farnesylation reaction, i.e., the transfer of the 15-carbon atom farnesyl group from farnesyl diphosphate (FPP) to a specific cysteine of protein substrates. Oncogenic Ras proteins, which are among the FTase substrates, are observed in about 20-30% of human cancer cells. Thus, FTase represents a target for anticancer drug design. Herein, we present a classical force-field-based and quantum mechanics/molecular mechanics (QM/MM) computational study of the FTase reaction mechanism. Our findings offer a detailed picture of the FTase catalytic pathway, describing structural features and the energetics of its saddle points. A moderate dissociation of the diphosphate group from the FPP is observed during the nucleophilic attack of the zinc-bound thiolate. At the transition state, a resonance structure is observed, which indicates the formation of a metastable carbocation. However, no stable intermediate is found along the reaction pathway. Thus, the reaction occurs via an associative mechanism with dissociative character, in agreement with the mechanism proposed by Fierke et al. (Biochemistry 2000, 39, 2593-2602 and Biochemistry 2003, 42, 9741-9748). Moreover, a fluorine-substituted FPP analogue (CF3-FPP) is used to investigate the inhibitory effect of fluorine, which in turn provides additional agreement with experimental data.
引用
收藏
页码:1657 / 1666
页数:10
相关论文
共 68 条
[41]  
Mu YQ, 1996, J AM CHEM SOC, V118, P1817
[42]   Protein farnesyltransferase inhibitors exhibit potent antimalarial activity [J].
Nallan, L ;
Bauer, KD ;
Bendale, P ;
Rivas, K ;
Yokoyama, K ;
Hornéy, CP ;
Pendyala, PR ;
Floyd, D ;
Lombardo, LJ ;
Williams, DK ;
Hamilton, A ;
Sebti, S ;
Windsor, WT ;
Weber, PC ;
Buckner, FS ;
Chakrabarti, D ;
Gelb, MH ;
Van Voorhis, WC .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (11) :3704-3713
[43]   A UNIFIED FORMULATION OF THE CONSTANT TEMPERATURE MOLECULAR-DYNAMICS METHODS [J].
NOSE, S .
JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (01) :511-519
[44]   2-Oxo-tetrahydro-1,8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials [J].
Olepu, Srinivas ;
Suryadevara, Praveen Kumar ;
Rivas, Kasey ;
Yokoyama, Kohei ;
Verlinde, Christophe L. M. J. ;
Chakrabarti, Debopam ;
Van Voorhis, Wesley C. ;
Gelb, Michael H. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) :494-497
[45]   Measurement of the α-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase [J].
Pais, June E. ;
Bowers, Katherine E. ;
Fierke, Carol A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (47) :15086-15087
[46]   HARD AND SOFT ACIDS AND BASES [J].
PEARSON, RG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1963, 85 (22) :3533-&
[47]   Scalable molecular dynamics with NAMD [J].
Phillips, JC ;
Braun, R ;
Wang, W ;
Gumbart, J ;
Tajkhorshid, E ;
Villa, E ;
Chipot, C ;
Skeel, RD ;
Kalé, L ;
Schulten, K .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1781-1802
[48]   Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation [J].
Pickett, JS ;
Bowers, KE ;
Hartman, HL ;
Fu, HW ;
Embry, AC ;
Casey, PJ ;
Fierke, CA .
BIOCHEMISTRY, 2003, 42 (32) :9741-9748
[49]   ISOPRENOID DIPHOSPHATE UTILIZATION BY RECOMBINANT HUMAN FARNESYL-PROTEIN TRANSFERASE - INTERACTIVE BINDING BETWEEN SUBSTRATES AND A PREFERRED KINETIC PATHWAY [J].
POMPLIANO, DL ;
SCHABER, MD ;
MOSSER, SD ;
OMER, CA ;
SHAFER, JA ;
GIBBS, JB .
BIOCHEMISTRY, 1993, 32 (32) :8341-8347
[50]   Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors [J].
Ready, Neal E. ;
Lipton, Alan ;
Zhu, Yali ;
Statkevich, Paul ;
Frank, Emily ;
Curtis, Dolores ;
Bukowski, Ronald M. .
CLINICAL CANCER RESEARCH, 2007, 13 (02) :576-583